Literature DB >> 10732929

Bisphosphonate therapy and vascular calcification.

M R Goldstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10732929

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis.

Authors:  Frederick Wolfe; Marcy B Bolster; Christopher M O'Connor; Kaleb Michaud; Kenneth W Lyles; Cathleen S Colón-Emeric
Journal:  J Bone Miner Res       Date:  2013-05       Impact factor: 6.741

2.  Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic women.

Authors:  László B Tankó; Gerong Qin; Peter Alexandersen; Yu Z Bagger; Claus Christiansen
Journal:  Osteoporos Int       Date:  2004-06-10       Impact factor: 4.507

Review 3.  Therapy for patients with CKD and low bone mineral density.

Authors:  Susan M Ott
Journal:  Nat Rev Nephrol       Date:  2013-10-08       Impact factor: 28.314

4.  Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method.

Authors:  N Cíftçíoglu; M A Miller-Hjelle; J T Hjelle; E O Kajander
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.